PI
ALNY icon

PEAK6 Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History

PEAK6 Investments’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$8.47M Hold
30,800
– – 0.02% 644
2024
Q2 		$7.48M Buy
30,800
+14,000
+83% +$2.21M 0.02% 631
2024
Q1 		$2.51M Sell
16,800
-22,300
-57% -$3.72M 0.01% 1261
2023
Q4 		$7.48M Buy
39,100
+1,000
+3% +$170K 0.03% 606
2023
Q3 		$6.75M Hold
38,100
– – 0.03% 569
2023
Q2 		$7.24M Buy
38,100
+7,600
+25% +$1.51M 0.03% 500
2023
Q1 		$6.11M Sell
30,500
-17,800
-37% -$3.74M 0.03% 611
2022
Q4 		$11.5M Buy
48,300
+400
+0.8% +$85.3K 0.07% 318
2022
Q3 		$9.59M Sell
47,900
-13,100
-21% -$2.5M 0.04% 472
2022
Q2 		$10.6M Buy
61,000
+38,100
+166% +$5.41M 0.02% 825
2022
Q1 		$3.74M Sell
22,900
-3,400
-13% -$518K 0.01% 1315
2021
Q4 		$4.46M Buy
+26,300
New +$4.89M 0.01% 1213
2021
Q3 		– Sell
-25,000
Closed -$4.24M – 5083
2021
Q2 		$4.24M Buy
+25,000
New +$3.66M 0.01% 1237
2021
Q1 		– Sell
-95,500
Closed -$12.4M – 4790
2020
Q4 		$12.4M Buy
95,500
+200
+0.2% +$26.7K 0.03% 575
2020
Q3 		$13.9M Hold
95,300
– – 0.03% 453
2020
Q2 		$14.1M Sell
95,300
-36,000
-27% -$4.85M 0.05% 364
2020
Q1 		$14.3M Buy
131,300
+19,300
+17% +$2.23M 0.08% 235
2019
Q4 		$12.9M Buy
112,000
+17,100
+18% +$1.7M 0.07% 306
2019
Q3 		$7.63M Buy
94,900
+81,900
+630% +$6.48M 0.05% 480
2019
Q2 		$943K Buy
+13,000
New +$997K 0.01% 1811

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PEAK6 Investments's ALNY Position: Q3 2024 in Review

PEAK6 Investments reduced its Alnylam Pharmaceuticals (ALNY) stake by 78% in Q3 2024, selling an estimated $543K and leaving 591 shares worth $163K. The position accounts for ﹤0.01% of the portfolio, ranked #2858.

PEAK6 Investments first reported a position in ALNY in Q2 2019 and has held it in 19 quarters since. The position peaked at $4.82M in Q2 2020. 566 funds tracked by Wall St. Rank hold ALNY as of Q3 2024.

  • PEAK6 Investments held 591 shares of Alnylam Pharmaceuticals worth $163K as of Q3 2024.
  • PEAK6 Investments sold 2,087 Alnylam Pharmaceuticals shares in Q3 2024, an estimated $543K.
  • Alnylam Pharmaceuticals made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2858 holding.
  • PEAK6 Investments first reported a position in Alnylam Pharmaceuticals in Q2 2019 and has held it in 19 quarters since.
  • PEAK6 Investments's Alnylam Pharmaceuticals position peaked at $4.82M in Q2 2020.
  • 566 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.